Skip to content

Study on the correlation between oral peri-implant inflammation and inflammatory factors

Study on the correlation between oral peri-implant inflammation and inflammatory factors

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400089420
Enrollment
Unknown
Registered
2024-09-09
Start date
2024-03-10
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peri-implantitis

Interventions

Group A healthy implant and the opposite natural tooth with the same name
:none
The inflammatory implants in group B were identical with the natural teeth on the opposite side.:none
C Healthy implants and inflammatory implants
D Natural teeth with the same name on the opposite side of healthy implants and natural teeth with the same name on the opposite side of inflammatory implants:none

Sponsors

The People’s Hospital of Dazu, Chongqing
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Male and female, aged 18 to 65 years old.. 2. No antibiotics, immunological agents or non-steroidal drugs were used within 3 months before the experiment. 3. Implant denture with normal function >3 months; 4. No pregnancy; 5. There is no occlusal trauma in the implant prosthesis. 6. Good compliance, oral hygiene maintenance after implantation; 7. In good health and with patient's informed consent.

Exclusion criteria

Exclusion criteria: 1. The heart, lungs and other important organs are not fully functional or suffer from other serious systemic diseases; 2. Abnormal coagulation function; 3. Immune function deficiency; 4. Patients with malignant tumor; 5. Patients with a history of mental illness or difficulty in verbal communication who cannot cooperate with treatment; 6. Female patients who are preparing for pregnancy, pregnancy or breastfeeding;

Design outcomes

Primary

MeasureTime frame
Lnterleukin-6,IL-6;Lnterleukin- 1ß,IL-1ß;Tumor necrosis factor-a,TNF-a;

Secondary

MeasureTime frame
Matrix metallo preteinases-8,MMP-8;

Countries

China

Contacts

Public ContactShan Geng

The People’s Hospital of Dazu, Chongqing

gengshan@cqmu.edu.cn+86 136 3788 8125

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026